Reduced visual function associated with infantile spasms in children on vigabatrin therapy

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 2, 2005, Pages 514-520

  Hammoudi, Dena S ^a,b   Lee, Sophia S F ^c   Madison, Adena ^a,b   Mirabella, Giuseppe ^a,d   Buncic, J Raymond ^a,b,d   Logan, William J ^a,b,d   Snead, O Carter ^a,b,d   Westall, Carol A ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CARBAMAZEPINE; CARNITINE; CLOBAZAM; DIAZEPAM; DOMPERIDONE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; OMEPRAZOLE; PHENOBARBITAL; PHENYTOIN; SALBUTAMOL; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; FEMALE; HERITABILITY; HUMAN; INFANTILE SPASM; MALE; NYSTAGMUS; PREMATURITY; PRIORITY JOURNAL; SEIZURE; STATISTICAL SIGNIFICANCE; VISION; VISUAL ACUITY; VISUAL CORTEX; VISUAL DEPRIVATION; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CONTRAST SENSITIVITY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; INFANT; MALE; SPASMS, INFANTILE; VIGABATRIN; VISION DISORDERS; VISUAL ACUITY;

EID: 13944255380     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0559     Document Type: Article

References (40)

1. Singer WD, Rabe EF, Haller JS. The effect of ACTH therapy upon infantile spasms. J Pediatr. 1980;96:485-489.
2. Appleton RE, Peters AC, Mumford JP, Shaw DE. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40:1627-1633.
3. Sills GJ, Butler E, Forrest G, et al. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia. 2003;44:886-892.
4. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ. 1997;314:180-181.
5. Comaish IF, German C, Brimlow GM, et al. The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms. Doc Ophthalmol. 2002;104:195-212.
6. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings (see comments). Neurology. 1998;50:614-618.
7. Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology. 2000;55:347-352.
8. Besch D, Kurtenbach A, Apfelstedt-Sylla E, et al. Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol. 2002;104:151-170.
9. Harding GF, Robertson KA, Edson AS, Barnes P, Wild J. Visual electrophysiological effect of a GABA transaminase blocker. Doc Ophthalmol. 1999;97:179-188.
10. Johnson MA, Krauss GL, Miller NR, Medura M, Paul SR. Visual function loss from vigabatrin: effect of stopping the drug. Neurology. 2000;55:40-45.
11. Westall CA, Nobile R, Morong S, et al. Changes in the electroretinogram resulting from discontinuation of vigabatrin in children. Doc Ophthalmol. 2003;107:299-309.
12. Nousiainen I, Kalviainen R, Mantyjarvi M. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers. Br J Ophthalmol. 2000;84:622-625.
13. Buncic JR, Westall CA, Panton CM, et al. The characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. Ophthalmology. 2004;111:1935-1942.
14. Jasper HH. Report of the committee on methods of clinical examination in electroencephalography. Electroencephalogr Clin Neurophysiol. 1958;10:370-375.
15. Perron AM. The Effect of Vigabatrin Treatment on Contrast Sensitivity in a Pediatric Population. Toronto, Ontario, Canada: Institute of Medical Sciences, University of Toronto; 2001.
16. Norcia AM, Tyler CW, Hamer RD, Wesemann W. Measurement of spatial contrast sensitivity with the swept contrast VEP. Vision Res. 1989;29:627-637.
17. Till C, Rovet JF, Koren G, Westall CA. Assessment of visual functions following prenatal exposure to organic solvents. Neurotoxicology. 2003;24:725-731.
18. Tyler CW, Apkarian P, Levi DM, Nakayama K. Rapid assessment of visual function: an electronic sweep technique for the pattern visual evoked potential. Invest Ophthaltnol Vis Sci. 1979;18:703-713.
19. Campbell FW, Maffei L. Electrophysiological evidence for the existence of orientation and size detectors in the human visual system. J Physiol. 1970;207:635-652.
20. Norcia AM, Tyler CW. Spatial frequency sweep VEP: visual acuity during the first year of life. Vision Res. 1985;25:1399-1408.
21. Norcia AM, Tyler CW, Hamer RD. Development of contrast sensitivity in the human infant. Vision Res. 1990;30:1475-1486.
22. Allen D, Tyler CW, Norcia AM. Development of grating acuity and contrast sensitivity in the central and peripheral visual field of the human infant. Vision Res. 1996;36:1945-1953.
23. Efron B, Tibshirani RJ. An introduction to the bootstrap. Monographs on Statistics and Applied Probability. Vol. 57. New York: Chapman & Hall; 1993.
24. Chernick MR. Bootstrap Methods: A Practitioners' Guide. New York: John Wiley & Sons Inc.; 1999.
25. Dunn OJ. Multiple comparisons using rank sums. Technometrics. 1964;6:241-252.
26. Brooks BP, Simpson JL, Leber SM, Robertson PL, Archer SM. Infantile spasms as a cause of acquired perinatal visual loss. J AAPOS. 2002;6:385-388.
27. Castano G, Lyons CJ, Jan JE, Connolly M. Cortical visual impairment in children with infantile spasms. J AAPOS. 2000;4:175-178.
28. Iinuma K, Haginoya K, Nagai M, et al. Visual abnormalities and occipital EEG discharges: risk factors for West syndrome. Epilepsia. 1994;35:806-809.
29. Sillito AM. The contribution of inhibitory mechanisms to the receptive field properties of neurones in the striate cortex of the cat. J Physiol. 1975;250:305-329.
30. Wolf W, Hicks TP, Albus K. The contribution of GABA-mediated inhibitory mechanisms to visual response properties of neurons in the kitten's striate cortex. J Neurosci. 1986;6:2779-2795.
31. Ramoa AS, Paradiso MA, Freeman RD. Blockade of intracortical inhibition in kitten striate cortex: effects on receptive field properties and associated loss of ocular dominance plasticity. Exp Brain Res. 1988;73:285-296.
32. Ito M, Mikawa H, Taniguchi T. Cerebrospinal fluid GABA levels in children with infantile spasms. Neurology. 1984;34:235-238.
33. Airaksinen E, Tuomisto L, Riikonen R. The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and the effects of ACTH treatment. Brain Dev. 1992;14:386-390.
34. Loscher W, Siemes H. Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia. 1985;26:314-319.
35. Hammond P. Cat retinal ganglion cells: size and shape of receptive field centres. J Physiol. 1974;242:99-118.
36. Sillito AM, Kemp JA. The influence of GABAergic inhibitory processes on the receptive field structure of X and Y cells in cat dorsal lateral geniculate nucleus (dLGN). Brain Res. 1983;277:63-77.
37. Sillito AM, Kemp JA, Milson JA, Berardi N. A re-evaluation of the mechanisms underlying simple cell orientation selectivity. Brain Res. 1980;194:517-520.
38. Hensch TK, Fagiolini M, Malaga N, et al. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science. 1998;282:1504-1508.
39. Morong S, Westal IC, Buncic JR, et al. Sweep visual evoked potentials in infants with infantile spasms before and during vigabatrin treatment (abstract). J Vision. 2002;2:A93.
40. Morong S. Assessing Visual Function in Infants and Children Treated with Vigabatrin. Thesis. Toronto, Ontario Canada: Institute of Medical Science., University of Toronto; 2003.